This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Matolcsy, A. Articles by Knowles, D. M. Search for Related Content PubMed PubMed Citation Articles by Matolcsy, A. Articles by Knowles, D. M.

American Journal of Pathology, Vol 147, 207-216, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

De novo CD5-positive and Richter's syndrome-associated diffuse large B cell lymphomas are genotypically distinct

A Matolcsy, A Chadburn and DM Knowles
Department of Pathology, New York Hospital, Cornell Medical Center, NY 10021, USA.

Diffuse large B cell lymphomas (DLBLs) represent a heterogeneous collection of aggressive non-Hodgkin's lymphomas that can arise either de novo or as a result of transformation from chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphomas, or lymphomas of mucosa-associated lymphoid tissue. A small percentage of DLBLs express the CD5 antigen. The majority of these cases have evolved from a pre-existing low grade non-Hodgkin's lymphoma (Richter's syndrome). However, we identified and characterized nine CD5-positive DLBLs in which the patients did not have a previous history or concomitant evidence of chronic lymphocytic leukemia, small lymphocytic lymphoma, follicular lymphoma, or mucosa-associated lymphoid tissue- associated non-Hodgkin's lymphoma, suggesting that they arose de novo. All nine cases expressed CD20 and monotypic immunoglobulin, all eight cases examined expressed CD19, CD22 and CD43, eight of the nine cases expressed HLA-DR, and two of eight cases expressed CD11c. None of the cases expressed CD3, CD10, CD11b, CD21, CD23 or CD30. CD5 expression by these cells was found to be identical to that of CD5-positive B cell chronic lymphocytic leukemia by quantitative polymerase chain reaction analysis of CD5 mRNA. These nine de novo CD5-positive DLBLs exhibited clonal immunoglobulin heavy and light chain gene rearrangements but lacked integration of the Epstein-Barr virus genome and structural alterations of the bcl-1, bcl-2, c-myc, H-ras, K-ras, and N-ras proto- oncogenes and the p53 tumor suppressor gene. However, bcl-6 proto- oncogene rearrangement, which is involved in chromosome band 3q27 aberrations, was found in four cases (44.4%). This is comparable with the frequency of bcl-6 gene rearrangement in CD5-negative DLBL. In contrast, bcl-6 gene rearrangement was absent in six cases of DLBL associated with Richter's syndrome. These findings suggest that de novo CD5-positive DLBLs are genotypically similar to CD5-negative DLBLs and may be pathogenetically distinct from the DLBLs associated with Richter's syndrome.

This article has been cited by other articles:

				A. M. Maeshima, H. Taniguchi, J. Nomoto, D. Maruyama, S.-W. Kim, T. Watanabe, Y. Kobayashi, K. Tobinai, and Y. Matsuno Secondary CD5+ Diffuse Large B-Cell Lymphoma Not Associated With Transformation of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (Richter Syndrome) Am J Clin Pathol, March 1, 2009; 131(3): 339 - 346. [Abstract] [Full Text] [PDF]

				M. Yamaguchi, N. Nakamura, R. Suzuki, Y. Kagami, M. Okamoto, R. Ichinohasama, T. Yoshino, J. Suzumiya, T. Murase, I. Miura, et al. De novo CD5+ diffuse large B-cell lymphoma: results of a detailed clinicopathological review in 120 patients Haematologica, August 1, 2008; 93(8): 1195 - 1202. [Abstract] [Full Text] [PDF]

				T. Katzenberger, A. Lohr, S. Schwarz, M. Dreyling, J. Schoof, C. Nickenig, S. Stilgenbauer, J. Kalla, M. M. Ott, H. K. Muller-Hermelink, et al. Genetic analysis of de novo CD5+ diffuse large B-cell lymphomas suggests an origin from a somatically mutated CD5+ progenitor B cell Blood, January 15, 2003; 101(2): 699 - 702. [Abstract] [Full Text] [PDF]

				T. Kobayashi, M. Yamaguchi, S. Kim, J. Morikawa, S. Ogawa, S. Ueno, E. Suh, E. Dougherty, I. Shmulevich, H. Shiku, et al. Microarray Reveals Differences in Both Tumors and Vascular Specific Gene Expression in de Novo CD5+ and CD5- Diffuse Large B-Cell Lymphomas Cancer Res., January 1, 2003; 63(1): 60 - 66. [Abstract] [Full Text] [PDF]

				M. Yamaguchi, M. Seto, M. Okamoto, R. Ichinohasama, N. Nakamura, T. Yoshino, J. Suzumiya, T. Murase, I. Miura, T. Akasaka, et al. De novo CD5+ diffuse large B-cell lymphoma: a clinicopathologic study of 109 patients Blood, February 1, 2002; 99(3): 815 - 821. [Abstract] [Full Text] [PDF]

				Z. Szereday, B. Csernus, M. Nagy, T. Laszlo, R. A. Warnke, and A. Matolcsy Somatic Mutation of the 5' Noncoding Region of the BCL-6 Gene Is Associated with Intraclonal Diversity and Clonal Selection in Histological Transformation of Follicular Lymphoma Am. J. Pathol., March 1, 2000; 156(3): 1017 - 1024. [Abstract] [Full Text] [PDF]

				M. Taniguchi, K. Oka, A. Hiasa, M. Yamaguchi, T. Ohno, K. Kita, and H. Shiku De Novo CD5+ Diffuse Large B-Cell Lymphomas Express VH Genes With Somatic Mutation Blood, February 15, 1998; 91(4): 1145 - 1151. [Abstract] [Full Text] [PDF]